Embryo metabolite analysis and implantation potential prediction using chemiluminescent microfluidic chips with dielectric wetting valves.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 41771854.
- Also identified by DOI 10.1038/s41467-026-69999-5 and PMC identifier 13065755.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Analysis of embryo metabolites offers a promising non-invasive strategy for assessing preimplantation developmental potential, yet the limited performance of current sensing platforms restricts physiological insights. Here we report a capillary-driven chemiluminescence microfluidic device equipped with three electrowetting valves, enabling simultaneous, offline quantification of glucose, lactate and pyruvate from as little as 3 μL of spent blastocyst culture medium (SBCM). Using a training set (n = 61) and validation set (n = 108) of human embryo transfers, we systematically recorded morphological development and clinical pregnancy outcomes. Metabolic flux analysis revealed that embryos with higher developmental potential consumed more glucose and pyruvate while producing more lactate. Integration of metabolic and morphological data yielded a predictive model of implantation potential with an area under the curve (AUC) of 92.0%, demonstrating robust performance. This platform establishes a powerful tool for embryo selection and may inform clinical decision-making in assisted reproduction.
Medical subject headings
- Embryo Implantation
- Embryo Transfer
- Luminescent Measurements
- Blastocyst